Only three patients of ours had ATIII < 70% (3 of the DIC patients) but we found a significant decrease in ATIII levels in a severe group than non-severe COVID-19 patients(95.24 ± 29.63 vs. 109.53 ± 18.39; P < 0.001). This evidence concerns the gene SERPINC1 and COVID-19.